Elixir

Recent Posts

CMS Part D Audit Report Lists Noncompliance Activities and Recommends Actions for Improvement

On July 18, 2023, the Center for Medicare and Medicare Services (CMS) released the “2022 Part C and Part D Program...

Read More

Choice of Specialty Pharmacy Can Impact Specialty Drug Spend

Payers can better manage specialty drug costs if they take a close look at the specialty pharmacies their members are...

Read More

Top 10 Part D Changes from the CMS-4201 Final Rule

On April 12, 2023, the Centers for Medicare & Medicaid Services (CMS) published Final Rule CMS-4201-F Contract Year...

Read More

Unmasking the Medications You Shouldn’t Be Paying For

Hundreds of prescription medications process every day and patients and plan sponsors pay for them because that's what...

Read More

NASH: The growing and costly disease you probably don’t know about but should

Nonalcoholic steatohepatitis (NASH) is a type of nonalcoholic fatty liver disease (NAFLD). Like its name states, NASH...

Read More

Updates to Biologics, COVID-19 and Medicare Part D: What You Need to Know

Spring has sprung and so have the announcements from Centers for Medicare and Medicaid Services (CMS). The month of...

Read More

The Speed and Accuracy of Mail Order with the Personal Care Members Need

When the pandemic hit, people learned new ways to work, shop and communicate. They also switched to mail order pharmacy...

Read More

The Inflation Reduction Act Kicks Off Big Changes to Medicare Prescription Coverage

The Inflation Reduction Act (IRA) was signed into law in August 2022 and went into effect January 1, 2023. The IRA...

Read More

Four Strategies to Successfully Manage Specialty Medications

While specialty medications provide a new level of hope for people being treated for serious conditions such as...

Read More

Five Pipeline Developments to Watch in 2023

From biosimilars and COVID-19 to gene therapy and microbiomes, there are several developments in the pipeline to watch...

Read More